Mounjaro 1 KwikPen 20 mg/2,4 ml (8,33 mg/ml)
1 KwikPen - 20 mg/2,4 ml (8,33 mg/ml) - Each pen delivers 4 doses of 5 mg.
The Mounjaro Pen is used for the administration of tirzepatide, a medication approved for managing type 2 diabetes in adults. It aids in improving blood sugar levels in conjunction with diet and exercise by mimicking the action of certain hormones involved in blood sugar regulation. Additionally, tirzepatide has been shown to aid in weight loss, which can be beneficial for individuals with type 2 diabetes looking to manage their weight alongside their blood sugar levels.
Active Ingredient: Tirzepatide
Turkish packaging
The Mounjaro Pen is an innovative medical device designed for the administration of Mounjaro (tirzepatide) injection, a medication approved for the treatment of type 2 diabetes. This pen makes the process of self-administering the medication straightforward and convenient, aiming to improve adherence to treatment regimens. It is pre-filled and disposable, ensuring that patients use a sterile device each time. The Mounjaro Pen comes with a fine needle, designed to minimize discomfort during injection. It features a dose selector, allowing patients to adjust their dose as prescribed by their healthcare provider. The pen's design includes a clear window to verify the dose before administration, enhancing safety and accuracy. It is compact and portable, enabling patients to manage their diabetes treatment on the go. The device includes detailed instructions, making it accessible even for individuals new to injectable medications. Mounjaro Pen's introduction into the market represents a significant advancement in diabetes care, offering a combination of efficacy, safety, and user-friendliness. Its development is a testament to the ongoing innovations in medical technology aimed at improving the quality of life for people with chronic conditions.